Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5087892 | 0.78 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL12123460 | 0.78 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL7883058 | 0.78 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL18108828 | 0.78 | ALDH1A1 (0.41) | ALDH1A1 | |
| Alcohol SCHEMBL11666408 | 0.71 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL1533292 | 0.67 | ALDH1A1 (0.31) | ALDH1A1TDP1 | |
| SCHEMBL575696 | 0.67 | — | — | |
| SCHEMBL17998202 | 0.67 | ALDH1A1 (0.38) | ALDH1A1TDP1 | |
| SCHEMBL181823 | 0.67 | — | — | |
| SCHEMBL686751 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4569559-A1 | GLASSY ORGANIC FRAMEWORK ION-CONDUCTIVE MEMBRANES | Wisconsin Alumni Research Foundation (US) | 2025-06-18 | — | — | EP | disclosed |
| US-20240055638-A1 | GLASSY ORGANIC FRAMEWORK ION-CONDUCTIVE MEMBRANES | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2024-02-15 | — | — | US | disclosed |
| WO-2024036130-A1 | GLASSY ORGANIC FRAMEWORK ION-CONDUCTIVE MEMBRANES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2024-02-15 | — | — | WO | disclosed |
| CN-116505080-B | Nonaqueous electrolyte and secondary battery | 深圳海辰储能控制技术有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-116505080-A | Nonaqueous electrolyte and secondary battery | 深圳海辰储能控制技术有限公司 | 2023-07-28 | — | — | CN | disclosed |
| US-10777850-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-09-15 | — | — | US | disclosed |
| US-20190051941-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-02-14 | — | — | US | disclosed |
| US-10177414-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-01-08 | — | — | US | disclosed |
| EP-3098893-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING SAME | MITSUBISHI CHEM CORP (JP) | 2017-11-29 | — | — | EP | disclosed |
| US-20160322669-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
| US-9461334-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20160211553-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| US-8859798-B2 | Isothiocyanate compounds, pharmaceutical compositions, and uses thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2014-10-14 | — | — | US | disclosed |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | TST, TREH, NFATC1 | ALDH1A1 1832/4885TDP1 3595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.